日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

3D reconstruction of human liver tissue at cellular resolution.

以细胞分辨率对人肝组织进行三维重建。

Fabyan Wesley B, Fortin Chelsea L, Goune Dorice L, Kenerson Heidi L, Simmonds Bohorquez Susana P, Liu Jonathan T C, Yeh Matthew M, Carr Rotonya M, Yeung Raymond S W, Stevens Kelly R

Soluble Triggering Receptor Expressed on Myeloid Cells 2 is a Biomarker but Not a Mediator of Fibrosing Steatohepatitis

髓系细胞表达的可溶性触发受体2是纤维化脂肪性肝炎的生物标志物,但并非其介质。

Dempsey, Joseph L; Savard, Christopher; Kothari, Vishal; Tang, Jingjing; Lee, Sum P; Bornfeldt, Karin E; Carr, Rotonya M; Ioannou, George N

Intravascular Hepatocyte Lipid Droplets Are Commonly Present in Hepatic Sinusoids, Portal Venules, and Central Veins in MASH

在弥漫性大疱性口炎(MASH)中,肝细胞内脂滴常见于肝窦、门静脉和中央静脉。

Ioannou, George N; Savard, Christopher; Dempsey, Joseph L; Carr, Rotonya M; Lee, Sum P

Metabolic dysfunction-associated steatotic liver disease and the gut microbiome: pathogenic insights and therapeutic innovations

代谢功能障碍相关脂肪肝疾病与肠道微生物群:致病机制及治疗创新

Schnabl, Bernd; Damman, Christopher J; Carr, Rotonya M

Development of an AI algorithm for early identification of MASLD in the electronic health record

开发一种人工智能算法,用于在电子健康记录中早期识别MASLD

Stuart, Ariana; Dotson, Ashley; Swarts, Katya; Granich, Marion; Yeung, Jessica; Thirumalai, Arthi; Dhyani, Manish; Perkins, James; Carr, Rotonya

Rapid identification and phenotyping of nonalcoholic fatty liver disease patients using a machine-based approach in diverse healthcare systems

利用基于机器的方法在不同的医疗保健系统中快速识别和表型分析非酒精性脂肪肝患者

Basile, Anna O; Verma, Anurag; Tang, Leigh Anne; Serper, Marina; Scanga, Andrew; Farrell, Ava; Destin, Brittney; Carr, Rotonya M; Anyanwu-Ofili, Anuli; Rajagopal, Gunaretnam; Krikhely, Abraham; Bessler, Marc; Reilly, Muredach P; Ritchie, Marylyn D; Tatonetti, Nicholas P; Wattacheril, Julia

Soluble TREM2 is a biomarker but not a mediator of fibrosing steatohepatitis

可溶性TREM2是纤维化脂肪性肝炎的生物标志物,但并非其介质。

Dempsey, Joseph L; Savard, Christopher; Kothari, Vishal; Tang, Jingjing; Lee, Sum P; Bornfeldt, Karin E; Carr, Rotonya M; Ioannou, George N

Pragmatic strategies to address health disparities along the continuum of care in chronic liver disease

应对慢性肝病连续护理过程中健康差异的务实策略

Brahmania, Mayur; Rogal, Shari; Serper, Marina; Patel, Arpan; Goldberg, David; Mathur, Amit; Wilder, Julius; Vittorio, Jennifer; Yeoman, Andrew; Rich, Nicole E; Lazo, Mariana; Kardashian, Ani; Asrani, Sumeet; Spann, Ashley; Ufere, Nneka; Verma, Manisha; Verna, Elizabeth; Simpson, Dinee; Schold, Jesse D; Rosenblatt, Russell; McElroy, Lisa; Wadhwani, Sharad I; Lee, Tzu-Hao; Strauss, Alexandra T; Chung, Raymond T; Aiza, Ignacio; Carr, Rotonya; Yang, Jin Mo; Brady, Carla; Fortune, Brett E

LiverMap pipeline for 3D imaging of human liver reveals volumetric spatial dysregulation of cirrhotic vasculobiliary architecture

LiverMap流程用于对人肝脏进行3D成像,揭示了肝硬化血管胆道结构的体积空间失调。

Fabyan, Wesley B; Fortin, Chelsea L; Kenerson, Heidi L; Simmonds, Susana P; Liu, Jonathan T C; Yeh, Matthew M; Carr, Rotonya M; Yeung, Raymond S W; Stevens, Kelly R

An integrated analysis of fecal microbiome and metabolomic features distinguish non-cirrhotic NASH from healthy control populations

粪便微生物组和代谢组特征的综合分析能够区分非肝硬化性NASH患者和健康对照人群。

Carr, Rotonya M; Li, Yun; Chau, Lillian; Friedman, Elliot S; Lee, Jung-Jin; Adorini, Luciano; Erickson, Mary; Zaru, Luna; Shringarpure, Reshma; MacConell, Leigh; Bittinger, Kyle; Li, Hongzhe; Wu, Gary D